To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06537843
Title Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia (VenCM)
Acronym VenCM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hospital Municipal Sao Jose
Indications
Therapies
Age Groups: adult | senior
Covered Countries BRA

Facility Status City State Zip Country Details
Hospital Ophir Loyola NOT_YET_RECRUITING Belem Brazil Details
Hospital de Clínicas da UFPR NOT_YET_RECRUITING Curitiba Brazil Details
Hospital Universitario Polydoro Ernani de Sao Thiago NOT_YET_RECRUITING Florianopolis Brazil Details
Hospital Amaral Carvalho RECRUITING Jaú Brazil Details
Hospital Municipal Sao Jose RECRUITING Joinville Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field